103 related articles for article (PubMed ID: 20159909)
21. [The abnormality of FcgammaRIIB1-mediated signaling and the hyperactivity of B cells from patients with systemic lupus erythematosus].
Peng KJ; Xiao LS; Fei Y; Wang SR
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Nov; 22(6):769-71. PubMed ID: 17077019
[TBL] [Abstract][Full Text] [Related]
22. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes.
Kim YM; Brinkmann MM; Paquet ME; Ploegh HL
Nature; 2008 Mar; 452(7184):234-8. PubMed ID: 18305481
[TBL] [Abstract][Full Text] [Related]
23. Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis.
Machida H; Ito S; Hirose T; Takeshita F; Oshiro H; Nakamura T; Mori M; Inayama Y; Yan K; Kobayashi N; Yokota S
Nephrol Dial Transplant; 2010 Aug; 25(8):2530-537. PubMed ID: 20181802
[TBL] [Abstract][Full Text] [Related]
24. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
25. B-cell anergy is maintained in anti-DNA transgenic NZB/NZW mice.
Kat I; Makdasi E; Fischel R; Eilat D
Int Immunol; 2010 Feb; 22(2):101-11. PubMed ID: 20038519
[TBL] [Abstract][Full Text] [Related]
26. TLR accessory molecules.
Akashi-Takamura S; Miyake K
Curr Opin Immunol; 2008 Aug; 20(4):420-5. PubMed ID: 18625310
[TBL] [Abstract][Full Text] [Related]
27. Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus.
Gies V; Schickel JN; Jung S; Joublin A; Glauzy S; Knapp AM; Soley A; Poindron V; Guffroy A; Choi JY; Gottenberg JE; Anolik JH; Martin T; Soulas-Sprauel P; Meffre E; Korganow AS
JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515028
[TBL] [Abstract][Full Text] [Related]
28. The endoplasmic reticulum stress-inducible protein, Herp, is a potential triggering antigen for anti-DNA response.
Hirabayashi Y; Oka Y; Ikeda T; Fujii H; Ishii T; Sasaki T; Harigae H
J Immunol; 2010 Mar; 184(6):3276-83. PubMed ID: 20147634
[TBL] [Abstract][Full Text] [Related]
29. Role of nucleic acid-sensing TLRs in diverse autoantibody specificities and anti-nuclear antibody-producing B cells.
Koh YT; Scatizzi JC; Gahan JD; Lawson BR; Baccala R; Pollard KM; Beutler BA; Theofilopoulos AN; Kono DH
J Immunol; 2013 May; 190(10):4982-90. PubMed ID: 23589617
[TBL] [Abstract][Full Text] [Related]
30. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Kanda N; Tsuchida T; Tamaki K
Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
[TBL] [Abstract][Full Text] [Related]
31. Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus.
Carter RH; Zhao H; Liu X; Pelletier M; Chatham W; Kimberly R; Zhou T
Arthritis Rheum; 2005 Dec; 52(12):3943-54. PubMed ID: 16320342
[TBL] [Abstract][Full Text] [Related]
32. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.
Barrat FJ; Meeker T; Gregorio J; Chan JH; Uematsu S; Akira S; Chang B; Duramad O; Coffman RL
J Exp Med; 2005 Oct; 202(8):1131-9. PubMed ID: 16230478
[TBL] [Abstract][Full Text] [Related]
33. Glomerular expression of toll-like receptor-9 in lupus nephritis but not in normal kidneys: implications for the amplification of the inflammatory response.
Papadimitraki ED; Tzardi M; Bertsias G; Sotsiou E; Boumpas DT
Lupus; 2009 Aug; 18(9):831-5. PubMed ID: 19578108
[TBL] [Abstract][Full Text] [Related]
34. Toll-like receptor activation in the pathogenesis of systemic lupus erythematosus.
Means TK; Luster AD
Ann N Y Acad Sci; 2005 Dec; 1062():242-51. PubMed ID: 16461805
[TBL] [Abstract][Full Text] [Related]
35. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
[TBL] [Abstract][Full Text] [Related]
36. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.
Christensen SR; Shupe J; Nickerson K; Kashgarian M; Flavell RA; Shlomchik MJ
Immunity; 2006 Sep; 25(3):417-28. PubMed ID: 16973389
[TBL] [Abstract][Full Text] [Related]
38. Toll-like receptor 9 in systemic lupus erythematosus, impact on glucocorticoid treatment.
Ghaly NR; Kotb NA; Nagy HM; Rageh el SM
J Dermatolog Treat; 2013 Dec; 24(6):411-7. PubMed ID: 22620859
[TBL] [Abstract][Full Text] [Related]
39. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.
Santiago-Raber ML; Dunand-Sauthier I; Wu T; Li QZ; Uematsu S; Akira S; Reith W; Mohan C; Kotzin BL; Izui S
J Autoimmun; 2010 Jun; 34(4):339-48. PubMed ID: 19944565
[TBL] [Abstract][Full Text] [Related]
40. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
Devi BS; Van Noordin S; Krausz T; Davies KA
J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]